Novo Holdings, a company specializing in life science investor with a focus on creating long-term value, and HealthQuad, a healthcare venture capital firm, led a $40m funding round in Qure.ai, a healthtech startup that uses artificial intelligence assistance for medical imaging diagnostics, with participation from Mass Mutual Ventures. “Every year our technology helps more than four million people across 50 countries. Our goal is to continue being bullish in our market expansion, especially in the US and Europe. We are committed to aiding healthcare professionals in diagnosing illnesses faster and with more detail and accuracy while automating most of the routine work. This is a win for all involved in healthcare, especially for patients across the globe who will benefit from vastly improved health outcomes,” Prashant Warier, Qure.ai CEO and Founder.